Pfizer in talks with India over expedited approval for Covid-19 vaccine
Vials and a medical syringe are seen in front of a displayed Pfizer logo in this illustration. Photo: Reuters/file
Pfizer is in discussions with the Indian government seeking an "expedited approval pathway" for its Covid-19 vaccine, its CEO Albert Bourla said on LinkedIn on Monday, announcing a donation of medicines worth more than $70 million.
"Unfortunately, our vaccine is not registered in India although our application was submitted months ago," he said.
For all latest news, follow The Daily Star's Google News channel. "We are currently discussing with the Indian government an expedited approval pathway to make our Pfizer-BioNTech vaccine available for use in the country."
Comments